Table of Content - Childhood Absence Epilepsy Treatment Market

Childhood absence epilepsy diagnosis revolves around identifying symptoms and categorizing the epilepsy type based on those symptoms. Diagnostic methods and techniques for childhood absence epilepsy include electroencephalogram (EEG)/video telemetry, magnetic resonance imaging (MRI scans), and blood tests. In electroencephalogram (EEG)/video telemetry, electrical signals from brain are recorded in a computer by asking the patient to hyperventilate for 3 to 5 minutes, which triggers an absence seizure. The EEG then shows spikes and wave discharges at 3 Hz (cycles per second) that are generalized in nature (similar on both sides of the brain). Structural causes behind epilepsy can be understood with the help of MRI scans (as some patients suffering from epilepsy due to brain damage can be found by a MRI scan). Blood tests may be required to diagnose any medical conditions, which may be the reason behind epilepsy.

Market Dynamics

Key players in the market are focused on the development of new drugs for the treatment of childhood absence epilepsy. Factors such as increasing prevalence of the disease, increasing accessibility of medications, and presence of drugs in pipeline for childhood absence epilepsy treatment (Insys therapeutics and Cavion, Inc.) are expected to boost the global childhood absence epilepsy treatment market growth. Product launches by generic manufacturers in the U.S. as well as globally is expected to support growth of the market. For instance, Dr. Reddy’s Laboratories launched generic lamotrigine orally disintegrating tablets in the U.S. in 2016. Moreover, a number of manufacturers such as Insys Therapeutics (Cannabidiol) and Cavion, Inc. (CX-8998) have drugs in phase II stage in clinical trials and these therapies are expected to be launched over the forecast period.

Key features of the study

This report provides in-depth analysis of childhood absence epilepsy treatment market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2018–2026), considering 2016 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global childhood absence epilepsy treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies
Key companies covered as a part of this study include Cavion, Inc., Pfizer, Inc., GlaxoSmithKline Plc, Insys Therapeutics, Inc., AbbVie, Inc., and Teva Pharmaceutical Industries Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, by technology up-gradation, market expansion, and marketing tactics
The global childhood absence epilepsy treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the childhood absence epilepsy treatment market

Market Segmentation

By Drug (Revenue, USD Mn, 2021-2033)
- Ethosuximide
- Valproate
- Lamotrigine
- Phase 2 Drugs
  - Cannabidiol Oral Solution
  - CX-8998
By Disease Type (Revenue, USD Mn, 2021-2033)
- Typical Absence Seizures
- Atypical Absence Seizures
By Region (Revenue, USD Mn, 2021-2033)
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - South Africa
  - Central Africa
  - North Africa
Key Players
- Cavion, Inc.
- Pfizer, Inc.
- GlaxoSmithKline Plc
- Insys Therapeutics, Inc.
- AbbVie, Inc.
- Teva Pharmaceutical Industries Ltd.

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Drug
  - Market Snapshot, By Disease Type
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Product Approval
- Collaboration/Merge/Acquisition
- Regulatory Landscape
- PEST Analysis
- Porter’s Five Forces Analysis
- Epidemiology
- Robust Pipeline Analysis
Global Childhood Absence Epilepsy Treatment Market, By Drug, 2021 – 2033, (USD Million)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Ethosuximide
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
- Valproate
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
- Lamotrigine
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
- Phase 2 Drugs
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
  - Segment Trends
    - Cannabidiol Oral Solution
    - CX-8998
Global Childhood Absence Epilepsy Treatment Market, By Disease Type, 2021 – 2033, (USD Million)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 – 2033
  - Segment Trends
- Typical Absence Seizures
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
- Atypical Absence Seizures
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Million)
Global Childhood Absence Epilepsy Treatment Market, By Region, 2021 – 2033, (USD Million)
- Introduction
  - Market Share Analysis, By Region, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, For Regions, 2022–2033
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Million)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Company Profile
  - Cavion, Inc.
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Pfizer, Inc.
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - GlaxoSmithKline Plc
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Insys Therapeutics, Inc.
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - AbbVie, Inc.
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
  - Teva Pharmaceutical Industries Ltd.
    - Company Highlights
    - Product Portfolio
    - Financial Performance
    - Recent Highlights
    - Market Strategies
- Analyst Views
Section
- References
- Research Methodology
- About Us

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now

Credibility and Certifications

860519526

9001:2015

27001:2022

Need a Custom Report?

EXISTING CLIENTELE